Thalidomide

Generic name: Pronounced as (tha li' doe mide)
Brand names
  • Thalomid®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 08/15/2019

Risk of severe, life-threatening birth defects caused by thalidomide.

For all people taking thalidomide:

Thalidomide must not be taken by women who are pregnant or who could become pregnant while taking this medication. Even a single dose of thalidomide taken during pregnancy can cause severe birth defects (physical problems present in the baby at birth) or death of the unborn baby. A program called Thalidomide REMS® (formerly known as the System for Thalidomide Education and Prescribing Safety [S.T.E.P.S.®]) has been approved by the Food and Drug Administration (FDA) to make sure that pregnant women do not take thalidomide and that women do not become pregnant while taking thalidomide. All people who are prescribed thalidomide, including men and women who cannot become pregnant, must be registered with Thalidomide REMS®, have a thalidomide prescription from a doctor who is registered with Thalidomide REMS®, and have the prescription filled at a pharmacy that is registered with Thalidomide REMS® in order to receive this medication.

You will need to see your doctor every month during your treatment to talk about your condition and any side effects you may be experiencing. At each visit, your doctor may give you a prescription for up to a 28-day supply of medication with no refills. You must have this prescription filled within 7 days.

Do not donate blood while you are taking thalidomide and for 4 weeks after your treatment.

Do not share thalidomide with anyone else, even someone who may have the same symptoms that you have.

For women taking thalidomide:

If you can become pregnant, you will need to meet certain requirements during your treatment with thalidomide. You need to meet these requirements even if you have a history of not being able to become pregnant. You may be excused from meeting these requirements only if you have not menstruated (had a period) for 24 months in a row, or you have had a hysterectomy (surgery to remove your uterus).

You must use two acceptable forms of birth control for 4 weeks before you begin to take thalidomide, during your treatment, and for 4 weeks after your treatment. Your doctor will tell you which forms of birth control are acceptable. You must use these two forms of birth control at all times unless you can guarantee that you will not have any sexual contact with a male for 4 weeks before your treatment, during your treatment, and for 4 weeks after your treatment.

Some medications can cause hormonal contraceptives to be less effective. If you plan to use hormonal contraceptives (birth control pills, patches, implants, injections, rings, or intrauterine devices) during your treatment with thalidomide, tell your doctor about all the medications, vitamins, and herbal supplements you are taking or plan to take. Be sure to mention: griseofulvin (Grifulvin); certain medications to treat human immunodeficiency virus (HIV) including amprenavir (Agenerase), atazanavir (Reyataz), darunavir (Prezista), fosamprenavir (Lexiva), indinavir (Crixivan), lopinavir (in Kaletra), nelfinavir (Viracept), ritonavir (Norvir, in Kaletra), saquinavir (Invirase), and tipranavir (Aptivus); certain medications for seizures including carbamazepine (Carbatrol, Equetro, Tegretol) and phenytoin (Dilantin, Phenytek); modafinil (Provigil); penicillin; rifampin (Rimactane, Rifadin); rifabutin (Mycobutin); and St. John's wort. Many other medications may interfere with the action of hormonal contraceptives, so be sure to tell your doctor all of the medications you are taking or plan to take, even those that do not appear on this list.

You must have two negative pregnancy tests before you can begin to take thalidomide. You will also need to be tested for pregnancy in a laboratory at certain times during your treatment. Your doctor will tell you when and where to have these tests.

Stop taking thalidomide and call your doctor right away if you think you are pregnant, you have a late, irregular, or missed menstrual period, you have any change in your menstrual bleeding, or you have sex without using two forms of birth control. In some cases, your doctor can prescribe emergency contraception ('the morning after pill') to prevent pregnancy. If you become pregnant during your treatment, your doctor is required to call the FDA and the manufacturer. Your doctor will also make sure you talk with a doctor who specializes in problems during pregnancy who can help you make choices that are best for you and your baby.

For men taking thalidomide:

Thalidomide is present in semen (fluid containing sperm that is released through the penis during orgasm). You must either use a latex or synthetic condom or completely avoid any sexual contact with a woman who is pregnant or may become pregnant while you are taking this medication and for 4 weeks after your treatment. This is required even if you have had a vasectomy (surgery to prevent sperm from leaving your body and causing pregnancy). Tell your doctor immediately if you have had unprotected sex with a woman who can become pregnant or if you think for any reason that your partner is pregnant.

Do not donate semen or sperm while you are taking thalidomide and for 4 weeks after your treatment.

Risk of blood clots:

If you are taking thalidomide to treat multiple myeloma (a type of cancer of the bone marrow), there is a risk that you will develop a blood clot in your arms, legs or lungs. This risk is greater when thalidomide is used along with other chemotherapy medications such as dexamethasone. Call your doctor immediately if you experience any of the following symptoms: pain, tenderness, redness, warmth, or swelling in the arms or legs; shortness of breath; or chest pain. Your doctor may prescribe an anticoagulant ('blood thinner') or aspirin to help stop clots from forming during your treatment with thalidomide.

Talk to your doctor about the risks of taking thalidomide.

Thalidomide is used along with dexamethasone to treat multiple myeloma in people who have been recently found to have this disease. It is also used alone or with other medications to treat and prevent skin symptoms of erythema nodosum leprosum (ENL; episodes of skin sores, fever, and nerve damage that occur in people with Hansen's disease [leprosy]). Thalidomide is in a class of medications called immunomodulatory agents. It treats multiple myeloma by strengthening the immune system to fight cancer cells. It treats ENL by blocking the action of certain natural substances that cause swelling.

Thalidomide comes as a capsule to take by mouth. Thalidomide is usually taken with water once a day at bedtime and at least 1 hour after an evening meal. If you are taking thalidomide to treat ENL, your doctor may tell you to take it more than once a day, at least 1 hour after meals. Take thalidomide at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take thalidomide exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Keep the capsules in their packaging until you are ready to take them. Do not open the capsules or handle them more than necessary. If your skin comes into contact with broken capsules or powder, wash the exposed area with soap and water.

The length of your treatment depends on how your symptoms respond to thalidomide and whether your symptoms return when you stop taking the medication. Your doctor may need to interrupt your treatment or reduce your dose if you experience certain side effects. Do not stop taking thalidomide without talking to your doctor. When your treatment is complete your doctor will probably decrease your dose gradually.

Thalidomide is also sometimes used to treat certain skin conditions involving swelling and irritation. It is also used to treat certain complications of human immunodeficiency virus (HIV) such as aphthous stomatitis (condition in which ulcers form in the mouth), HIV-associated diarrhea, HIV-associated wasting syndrome, certain infections, and Kaposi's sarcoma (a type of skin cancer). Thalidomide has also been used to treat some types of cancer and tumors, severe weight loss in patients with weakened immune systems, chronic graft versus host disease (a complication that can occur after a bone marrow transplant in which the newly transplanted material attacks the transplant recipient's body), and Crohn's disease (a condition in which the body attacks the lining of the digestive tract, causing pain, diarrhea, weight loss, and fever). Talk to your doctor about the risks of using this medication for your condition.

This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking thalidomide,

  • tell your doctor and pharmacist if you are allergic to thalidomide or any other medications.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention the medications listed in the IMPORTANT WARNING section and any of the following: antidepressants; barbiturates such as pentobarbital (Nembutal), phenobarbital, and secobarbital (Seconal); chlorpromazine; didanosine (Videx); medications for anxiety, mental illness, or seizures; certain chemotherapy medications for cancer such as cisplatin (Platinol), paclitaxel (Abraxane, Taxol), and vincristine;reserpine (Serpalan); sedatives; sleeping pills; and tranquilizers. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have or have ever had human immunodeficiency virus (HIV), acquired immunodeficiency syndrome (AIDS), a low level of white blood cells in your blood, or seizures.

  • tell your doctor if you are breastfeeding.

  • you should know that thalidomide may make you drowsy. Do not drive a car, operate machinery, or do other activities that require you to be fully alert until you know how this medication affects you.

  • ask your doctor about the safe use of alcoholic beverages while you are taking thalidomide. Alcohol can make the side effects from thalidomide worse.

  • you should know that thalidomide may cause dizziness, lightheadedness, and fainting when you get up too quickly from a lying position. To help avoid this problem, get out of bed slowly, resting your feet on the floor for a few minutes before standing up.

  • you should know that thalidomide is present in your blood and body fluids. Anyone who may come into contact with these fluids should wear gloves or wash any exposed areas of skin with soap and water.

Unless your doctor tells you otherwise, continue your normal diet.

Take the missed dose as soon as you remember it. However, if it is less than 12 hours until your next scheduled dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Thalidomide may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • drowsiness

    • confusion

    • anxiety

    • depression or mood changes

    • difficulty falling asleep or staying asleep

    • bone, muscle, joint, or back pain

    • weakness

    • headache

    • change in appetite

    • weight changes

    • nausea

    • constipation

    • dry mouth

    • dry skin

    • pale skin

    • uncontrollable shaking of a part of the body

    • swelling of the hands, feet, ankles, or lower legs

    • difficulty achieving or maintaining an erection

  • Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately or get emergency medical treatment:

    • rash

    • itching

    • hives

    • blistering and peeling skin

    • swelling of the face, throat, tongue, lips, or eyes

    • hoarseness

    • difficulty swallowing or breathing

    • fever, sore throat, chills, cough, or other signs of infection

    • slow or fast heartbeat

    • seizures

  • Thalidomide may cause nerve damage that can be severe and permanent. This damage may occur any time during or after your treatment. Your doctor will examine you regularly to see how thalidomide has affected your nervous system. If you experience any of the following symptoms, stop taking thalidomide and call your doctor immediately: numbness, tingling, pain, or burning in the hands and feet.

  • Thalidomide may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your body's response to thalidomide.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Montelukast Montelukast The metabolism of Thalidomide can be decreased when combined with Montelukast.
Leflunomide Leflunomide The risk or severity of adverse effects can be increased when Thalidomide is combined with Leflunomide.
Delavirdine Delavirdine The metabolism of Thalidomide can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Nevirapine can be increased when combined with Thalidomide.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be increased when combined with Thalidomide.
Dolasetron Dolasetron Dolasetron may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Alendronate Alendronate The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Thalidomide is combined with Alendronic acid.
Anagrelide Anagrelide The risk or severity of bleeding can be increased when Anagrelide is combined with Thalidomide.
Candesartan Candesartan The metabolism of Candesartan can be decreased when combined with Thalidomide.
Cilostazol Cilostazol The serum concentration of Cilostazol can be increased when it is combined with Thalidomide.
Clopidogrel Clopidogrel The metabolism of Clopidogrel can be increased when combined with Thalidomide.
Diphenoxylate Diphenoxylate Diphenoxylate may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The metabolism of Erythromycin can be increased when combined with Thalidomide.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may increase the thrombogenic activities of Thalidomide.
Fenofibrate Fenofibrate The metabolism of Thalidomide can be decreased when combined with Fenofibrate.
Guanfacine Guanfacine Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Mycophenolate Mycophenolate The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Thalidomide.
Naratriptan Naratriptan Naratriptan may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Paregoric Paregoric Morphine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Penbutolol Penbutolol The risk or severity of adverse effects can be increased when Thalidomide is combined with Acebutolol.
Pentazocine Pentazocine Pentazocine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Prednisone Prednisone The risk or severity of adverse effects can be increased when Prednisone is combined with Thalidomide.
Reserpine Reserpine Reserpine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Rizatriptan Rizatriptan Rizatriptan may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Sumatriptan Sumatriptan Sumatriptan may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Tacrolimus Tacrolimus Tacrolimus may increase the immunosuppressive activities of Thalidomide.
Tiludronate Tiludronate The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Thalidomide is combined with Etidronic acid.
Tizanidine Tizanidine Tizanidine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Triamcinolone Triamcinolone The risk or severity of adverse effects can be increased when Triamcinolone is combined with Thalidomide.
Zolmitriptan Zolmitriptan Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Fluconazole Injection Fluconazole Injection The metabolism of Thalidomide can be decreased when combined with Fluconazole.
Hydromorphone Injection Hydromorphone Injection Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Thalidomide.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Thalidomide.
Meperidine Injection Meperidine Injection Meperidine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Thalidomide.
Metoclopramide Injection Metoclopramide Injection The risk or severity of sedation can be increased when Metoclopramide is combined with Thalidomide.
Metronidazole Injection Metronidazole Injection The metabolism of Thalidomide can be decreased when combined with Metronidazole.
Morphine Injection Morphine Injection Morphine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Pamidronate Injection Pamidronate Injection The risk or severity of nephrotoxicity can be increased when Thalidomide is combined with Pamidronic acid.
Zidovudine Injection Zidovudine Injection The risk or severity of adverse effects can be increased when Zidovudine is combined with Thalidomide.
Altretamine Altretamine Amphetamine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Cyclosporine Cyclosporine Thalidomide may increase the immunosuppressive activities of Cyclosporine.
Ondansetron Ondansetron Ondansetron may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding can be increased when Enoxaparin is combined with Thalidomide.
Granisetron Granisetron Granisetron may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Torsemide Torsemide The metabolism of Thalidomide can be decreased when combined with Torasemide.
Olanzapine Olanzapine Olanzapine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Alosetron Alosetron Alosetron may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Entacapone Entacapone Entacapone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Eprosartan Eprosartan The risk or severity of adverse effects can be increased when Thalidomide is combined with Eprosartan.
Hydroxychloroquine Hydroxychloroquine The risk or severity of adverse effects can be increased when Thalidomide is combined with Hydroxychloroquine.
Meloxicam Meloxicam The metabolism of Thalidomide can be decreased when combined with Meloxicam.
Oxcarbazepine Oxcarbazepine Oxcarbazepine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Pantoprazole Pantoprazole The metabolism of Pantoprazole can be decreased when combined with Thalidomide.
Risedronate Risedronate The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Thalidomide is combined with Risedronic acid.
Telmisartan Telmisartan The risk or severity of adverse effects can be increased when Thalidomide is combined with Telmisartan.
Temozolomide Temozolomide The risk or severity of adverse effects can be increased when Temozolomide is combined with Thalidomide.
Zaleplon Zaleplon Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Anakinra Anakinra The metabolism of Thalidomide can be increased when combined with Anakinra.
Desloratadine Desloratadine Desloratadine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Linezolid Linezolid Linezolid may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Thalidomide.
Trimipramine Trimipramine Trimipramine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Etanercept Injection Etanercept Injection The metabolism of Thalidomide can be increased when combined with Etanercept.
Glycopyrrolate Glycopyrrolate Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Modafinil Modafinil The metabolism of Thalidomide can be decreased when combined with Modafinil.
Perindopril Perindopril The risk or severity of adverse effects can be increased when Thalidomide is combined with Perindopril.
Sirolimus Sirolimus The risk or severity of adverse effects can be increased when Sirolimus is combined with Thalidomide.
Dutasteride Dutasteride The metabolism of Dutasteride can be increased when combined with Thalidomide.
Epinephrine Injection Epinephrine Injection The metabolism of Thalidomide can be decreased when combined with Epinephrine.
Epirubicin Epirubicin The risk or severity of adverse effects can be increased when Epirubicin is combined with Thalidomide.
Eplerenone Eplerenone The metabolism of Eplerenone can be increased when combined with Thalidomide.
Escitalopram Escitalopram Escitalopram may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Olmesartan Olmesartan The risk or severity of adverse effects can be increased when Thalidomide is combined with Olmesartan.
Zonisamide Zonisamide Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Adalimumab Injection Adalimumab Injection The metabolism of Thalidomide can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Atomoxetine Atomoxetine Atomoxetine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Dexmethylphenidate Dexmethylphenidate Dexmethylphenidate may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Glatiramer Injection Glatiramer Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Glatiramer.
Atazanavir Atazanavir The metabolism of Atazanavir can be decreased when combined with Thalidomide.
Almotriptan Almotriptan Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Eletriptan Eletriptan Eletriptan may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be increased when combined with Thalidomide.
Vardenafil Vardenafil The metabolism of Vardenafil can be increased when combined with Thalidomide.
Aprepitant Aprepitant The metabolism of Aprepitant can be increased when combined with Thalidomide.
Tadalafil Tadalafil The metabolism of Tadalafil can be increased when combined with Thalidomide.
Frovatriptan Frovatriptan Frovatriptan may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Progesterone Progesterone Progesterone may increase the thrombogenic activities of Thalidomide.
Apomorphine Injection Apomorphine Injection Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Darbepoetin Alfa Injection Darbepoetin Alfa Injection The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Thalidomide.
Infliximab Injection Infliximab Injection The metabolism of Thalidomide can be increased when combined with Infliximab.
Oxandrolone Oxandrolone The metabolism of Thalidomide can be decreased when combined with Oxandrolone.
Protriptyline Protriptyline Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Duloxetine Duloxetine Duloxetine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Norethindrone Norethindrone Norethisterone may increase the thrombogenic activities of Thalidomide.
Trospium Trospium Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Bosentan Bosentan The metabolism of Thalidomide can be increased when combined with Bosentan.
Natalizumab Injection Natalizumab Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Natalizumab.
Erlotinib Erlotinib The metabolism of Erlotinib can be increased when combined with Thalidomide.
Eszopiclone Eszopiclone Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Palifermin Palifermin The therapeutic efficacy of Palifermin can be decreased when used in combination with Thalidomide.
Solifenacin Solifenacin Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
Voriconazole Voriconazole The metabolism of Thalidomide can be decreased when combined with Voriconazole.
Zoledronic Acid Injection Zoledronic Acid Injection The risk or severity of jaw osteonecrosis can be increased when Thalidomide is combined with Zoledronic acid.
Dextroamphetamine Dextroamphetamine Amphetamine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Thalidomide.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Thalidomide.
Sodium Oxybate Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Ibandronate Ibandronate The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Thalidomide is combined with Ibandronate.
Isocarboxazid Isocarboxazid Isocarboxazid may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Ramelteon Ramelteon Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Darifenacin Darifenacin Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.
Fentanyl Fentanyl Fentanyl may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Pregabalin Pregabalin Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Felbamate Felbamate Felbamate may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Abatacept Injection Abatacept Injection The metabolism of Thalidomide can be increased when combined with Abatacept.
Rasagiline Rasagiline Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Imatinib Imatinib The risk or severity of adverse effects can be increased when Imatinib is combined with Thalidomide.
Bevacizumab Injection Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Thalidomide.
Gefitinib Gefitinib The metabolism of Thalidomide can be decreased when combined with Gefitinib.
Paliperidone Paliperidone Paliperidone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Bortezomib Bortezomib The risk or severity of adverse effects can be increased when Bortezomib is combined with Thalidomide.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Thalidomide.
Hepatitis B Vaccine Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Thalidomide.
Influenza Vaccine, Inactivated or Recombinant Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Thalidomide.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Thalidomide.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Thalidomide.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Thalidomide.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Thalidomide.
Aliskiren Aliskiren The risk or severity of adverse effects can be increased when Thalidomide is combined with Aliskiren.
Pemetrexed Injection Pemetrexed Injection The risk or severity of adverse effects can be increased when Pemetrexed is combined with Thalidomide.
Dimenhydrinate Dimenhydrinate Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Nabilone Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Vorinostat Vorinostat The risk or severity of adverse effects can be increased when Thalidomide is combined with Vorinostat.
Sorafenib Sorafenib The risk or severity of adverse effects can be increased when Sorafenib is combined with Thalidomide.
Sunitinib Sunitinib The risk or severity of adverse effects can be increased when Thalidomide is combined with Sunitinib.
Dronabinol Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Lapatinib Lapatinib The metabolism of Lapatinib can be increased when combined with Thalidomide.
Levocetirizine Levocetirizine Levocetirizine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Dasatinib Dasatinib The risk or severity of adverse effects can be increased when Thalidomide is combined with Dasatinib.
Armodafinil Armodafinil The metabolism of Thalidomide can be decreased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Thalidomide.
Temsirolimus Temsirolimus The risk or severity of adverse effects can be increased when Thalidomide is combined with Temsirolimus.
Nelarabine Injection Nelarabine Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Nelarabine.
Lenalidomide Lenalidomide The risk or severity of adverse effects can be increased when Lenalidomide is combined with Thalidomide.
Nilotinib Nilotinib The risk or severity of adverse effects can be increased when Thalidomide is combined with Nilotinib.
Bexarotene Bexarotene The risk or severity of adverse effects can be increased when Bexarotene is combined with Thalidomide.
Budesonide Budesonide The risk or severity of adverse effects can be increased when Thalidomide is combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Thalidomide.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Decitabine.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection Botulinum toxin type A may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Etravirine Etravirine The metabolism of Etravirine can be decreased when combined with Thalidomide.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Arsenic trioxide.
Mitoxantrone Injection Mitoxantrone Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Mitoxantrone.
Desvenlafaxine Desvenlafaxine Desvenlafaxine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Nebivolol Nebivolol The metabolism of Nebivolol can be decreased when combined with Thalidomide.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Tretinoin is combined with Thalidomide.
Bendamustine Injection Bendamustine Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Bendamustine.
Flecainide Flecainide The metabolism of Thalidomide can be decreased when combined with Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Thalidomide can be increased when combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Ixabepilone.
Irinotecan Injection Irinotecan Injection The risk or severity of adverse effects can be increased when Irinotecan is combined with Thalidomide.
Estramustine Estramustine The risk or severity of adverse effects can be increased when Thalidomide is combined with Estramustine.
Praziquantel Praziquantel The metabolism of Praziquantel can be increased when combined with Thalidomide.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Thalidomide.
Rufinamide Rufinamide Rufinamide may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Midazolam Midazolam Midazolam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Dexrazoxane Injection Dexrazoxane Injection The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Thalidomide.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Thalidomide.
Milnacipran Milnacipran Milnacipran may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Dexlansoprazole Dexlansoprazole The metabolism of Dexlansoprazole can be decreased when combined with Thalidomide.
Fesoterodine Fesoterodine Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
Betaxolol Betaxolol The risk or severity of adverse effects can be increased when Thalidomide is combined with Betaxolol.
Iloperidone Iloperidone Iloperidone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Prasugrel Prasugrel The risk or severity of bleeding can be increased when Prasugrel is combined with Thalidomide.
Lacosamide Lacosamide Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Everolimus Everolimus The risk or severity of adverse effects can be increased when Thalidomide is combined with Everolimus.
Dronedarone Dronedarone The metabolism of Dronedarone can be increased when combined with Thalidomide.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection Botulinum toxin type A may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Pralatrexate Injection Pralatrexate Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Pralatrexate.
Palonosetron Injection Palonosetron Injection Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Saxagliptin Saxagliptin The metabolism of Saxagliptin can be increased when combined with Thalidomide.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be increased when combined with Thalidomide.
Tapentadol Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Topotecan Topotecan The risk or severity of adverse effects can be increased when Topotecan is combined with Thalidomide.
Golimumab Injection Golimumab Injection The metabolism of Thalidomide can be increased when combined with Golimumab.
Pazopanib Pazopanib The risk or severity of adverse effects can be increased when Thalidomide is combined with Pazopanib.
Asenapine Asenapine Asenapine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Vigabatrin Vigabatrin Vigabatrin may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Thalidomide.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Thalidomide.
Ulipristal Ulipristal Ulipristal may increase the thrombogenic activities of Thalidomide.
Levonorgestrel Levonorgestrel Levonorgestrel may increase the thrombogenic activities of Thalidomide.
Oxymorphone Oxymorphone Oxymorphone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Denosumab Injection Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Thalidomide.
Dabigatran Dabigatran The risk or severity of bleeding can be increased when Dabigatran is combined with Thalidomide.
Tocilizumab Injection Tocilizumab Injection The metabolism of Thalidomide can be increased when combined with Tocilizumab.
Fingolimod Fingolimod Thalidomide may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Eribulin.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection Botulinum toxin type A may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Cabazitaxel Injection Cabazitaxel Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Cabazitaxel.
Lurasidone Lurasidone Lurasidone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Vilazodone Vilazodone Vilazodone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Denileukin Diftitox Injection Denileukin Diftitox Injection The risk or severity of adverse effects can be increased when Aldesleukin is combined with Thalidomide.
Sipuleucel-T Injection Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Thalidomide.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Belimumab.
Azilsartan Azilsartan The risk or severity of adverse effects can be increased when Thalidomide is combined with Azilsartan medoxomil.
Busulfan Injection Busulfan Injection The risk or severity of adverse effects can be increased when Busulfan is combined with Thalidomide.
Roflumilast Roflumilast Roflumilast may increase the immunosuppressive activities of Thalidomide.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Thalidomide can be decreased when combined with Cyclophosphamide.
Abiraterone Abiraterone The metabolism of Thalidomide can be decreased when combined with Abiraterone.
Rivaroxaban Rivaroxaban The metabolism of Rivaroxaban can be increased when combined with Thalidomide.
Ticagrelor Ticagrelor The risk or severity of bleeding can be increased when Ticagrelor is combined with Thalidomide.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Brentuximab vedotin.
Ruxolitinib Ruxolitinib The risk or severity of adverse effects can be increased when Thalidomide is combined with Ruxolitinib.
Clobazam Clobazam Clobazam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Vemurafenib Vemurafenib The metabolism of Thalidomide can be decreased when combined with Vemurafenib.
Vismodegib Vismodegib The metabolism of Thalidomide can be decreased when combined with Vismodegib.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Belatacept.
Ivacaftor Ivacaftor The metabolism of Ivacaftor can be increased when combined with Thalidomide.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Thalidomide.
Axitinib Axitinib The metabolism of Axitinib can be increased when combined with Thalidomide.
Crizotinib Crizotinib The metabolism of Crizotinib can be increased when combined with Thalidomide.
Melphalan Injection Melphalan Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Melphalan.
Cabergoline Cabergoline Cabergoline may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Ambrisentan Ambrisentan The metabolism of Ambrisentan can be increased when combined with Thalidomide.
Eculizumab Injection Eculizumab Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Eculizumab.
Fondaparinux Injection Fondaparinux Injection The risk or severity of bleeding can be increased when Fondaparinux is combined with Thalidomide.
Pertuzumab Injection Pertuzumab Injection The risk or severity of cardiotoxicity can be increased when Thalidomide is combined with Pertuzumab.
Ezogabine Ezogabine Tiagabine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Carfilzomib Injection Carfilzomib Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Carfilzomib.
Iloprost Iloprost The risk or severity of bleeding can be increased when Iloprost is combined with Thalidomide.
Enzalutamide Enzalutamide The metabolism of Enzalutamide can be increased when combined with Thalidomide.
Regorafenib Regorafenib The metabolism of Thalidomide can be decreased when combined with Regorafenib.
Bosutinib Bosutinib The risk or severity of adverse effects can be increased when Thalidomide is combined with Bosutinib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Corticotropin.
Teriflunomide Teriflunomide The risk or severity of adverse effects can be increased when Thalidomide is combined with Teriflunomide.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Thalidomide.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Thalidomide.
Tofacitinib Tofacitinib Thalidomide may increase the immunosuppressive activities of Tofacitinib.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Thalidomide is combined with Dimethyl fumarate.
Ponatinib Ponatinib The risk or severity of adverse effects can be increased when Thalidomide is combined with Ponatinib.
Pomalidomide Pomalidomide Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Trastuzumab emtansine.
Apixaban Apixaban The metabolism of Apixaban can be increased when combined with Thalidomide.
Canagliflozin Canagliflozin The risk or severity of adverse effects can be increased when Thalidomide is combined with Canagliflozin.
Methazolamide Methazolamide The risk or severity of adverse effects can be increased when Methazolamide is combined with Thalidomide.
Dabrafenib Dabrafenib The metabolism of Thalidomide can be increased when combined with Dabrafenib.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Thalidomide.
Levomilnacipran Levomilnacipran Levomilnacipran may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Vortioxetine Vortioxetine Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Perampanel Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Ibrutinib Ibrutinib The risk or severity of adverse effects can be increased when Thalidomide is combined with Ibrutinib.
Avanafil Avanafil The risk or severity of hypotension can be increased when Avanafil is combined with Thalidomide.
Ketorolac Injection Ketorolac Injection The metabolism of Thalidomide can be decreased when combined with Ketorolac.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Obinutuzumab.
Dapagliflozin Dapagliflozin The risk or severity of adverse effects can be increased when Thalidomide is combined with Dapagliflozin.
Apremilast Apremilast The metabolism of Thalidomide can be increased when combined with Apremilast.
Ceritinib Ceritinib The metabolism of Thalidomide can be decreased when combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Thalidomide can be increased when combined with Siltuximab.
Eslicarbazepine Eslicarbazepine Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Vedolizumab Injection Vedolizumab Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Belinostat.
Idelalisib Idelalisib The risk or severity of adverse effects can be increased when Thalidomide is combined with Idelalisib.
Testosterone Injection Testosterone Injection The metabolism of Testosterone can be increased when combined with Thalidomide.
Oritavancin Injection Oritavancin Injection The metabolism of Thalidomide can be decreased when combined with Oritavancin.
Empagliflozin Empagliflozin The risk or severity of adverse effects can be increased when Thalidomide is combined with Empagliflozin.
Vorapaxar Vorapaxar The risk or severity of bleeding can be increased when Vorapaxar is combined with Thalidomide.
Hydrocodone Hydrocodone Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Suvorexant Suvorexant Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Edoxaban Edoxaban The risk or severity of bleeding can be increased when Edoxaban is combined with Thalidomide.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Peginterferon beta-1a.
Olaparib Olaparib The risk or severity of adverse effects can be increased when Thalidomide is combined with Olaparib.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Blinatumomab.
Methamphetamine Methamphetamine Metamfetamine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Tasimelteon Tasimelteon Tasimelteon may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Riociguat Riociguat The risk or severity of adverse effects can be increased when Thalidomide is combined with Riociguat.
Pirfenidone Pirfenidone The risk or severity of adverse effects can be increased when Thalidomide is combined with Pirfenidone.
Secukinumab Injection Secukinumab Injection The metabolism of Thalidomide can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection Risperidone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Palbociclib Palbociclib The risk or severity of adverse effects can be increased when Thalidomide is combined with Palbociclib.
Lenvatinib Lenvatinib The metabolism of Thalidomide can be decreased when combined with Lenvatinib.
Panobinostat Panobinostat The risk or severity of adverse effects can be increased when Thalidomide is combined with Panobinostat.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection Haloperidol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Amiloride Amiloride The risk or severity of adverse effects can be increased when Amiloride is combined with Thalidomide.
Macitentan Macitentan Thalidomide may increase the hypotensive activities of Macitentan.
Flibanserin Flibanserin Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Prednisolone Prednisolone The risk or severity of adverse effects can be increased when Prednisolone is combined with Thalidomide.
Daclatasvir Daclatasvir The metabolism of Daclatasvir can be increased when combined with Thalidomide.
Brexpiprazole Brexpiprazole Brexpiprazole may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Ziprasidone Injection Ziprasidone Injection Ziprasidone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Cariprazine Cariprazine Cariprazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Mepolizumab.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Thalidomide.
Lesinurad Lesinurad The metabolism of Lesinurad can be decreased when combined with Thalidomide.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Thalidomide.
Dexamethasone Injection Dexamethasone Injection The risk or severity of thromboembolism can be increased when Dexamethasone is combined with Thalidomide.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding can be increased when Defibrotide is combined with Thalidomide.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Ixekizumab.
Brivaracetam Injection Brivaracetam Injection Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Cobicistat Cobicistat The metabolism of Cobicistat can be increased when combined with Thalidomide.
Selexipag Selexipag Thalidomide may increase the hypotensive activities of Selexipag.
Pimavanserin Pimavanserin Pimavanserin may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Diphenhydramine Injection Diphenhydramine Injection Diphenhydramine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Furosemide Injection Furosemide Injection The risk or severity of adverse effects can be increased when Furosemide is combined with Thalidomide.
Rucaparib Rucaparib The metabolism of Thalidomide can be decreased when combined with Rucaparib.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Brodalumab.
Doxepin (Insomnia) Doxepin (Insomnia) Doxepin may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Deutetrabenazine Deutetrabenazine The metabolism of Deutetrabenazine can be increased when combined with Thalidomide.
Valbenazine Valbenazine The metabolism of Valbenazine can be increased when combined with Thalidomide.
Deflazacort Deflazacort The risk or severity of adverse effects can be increased when Thalidomide is combined with Deflazacort.
Safinamide Safinamide Safinamide may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Ocrelizumab Injection Ocrelizumab Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Ocrelizumab.
Sarilumab Injection Sarilumab Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Sarilumab.
Midostaurin Midostaurin The metabolism of Thalidomide can be decreased when combined with Midostaurin.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Guselkumab.
Enasidenib Enasidenib The metabolism of Thalidomide can be decreased when combined with Enasidenib.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be increased when combined with Thalidomide.
Delafloxacin Delafloxacin The metabolism of Thalidomide can be increased when combined with Delafloxacin.
Betrixaban Betrixaban The risk or severity of bleeding can be increased when Betrixaban is combined with Thalidomide.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Thalidomide.
Buprenorphine Injection Buprenorphine Injection Buprenorphine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Apalutamide Apalutamide The metabolism of Thalidomide can be increased when combined with Apalutamide.
Penicillamine Penicillamine The risk or severity of adverse effects can be increased when Penicillamine is combined with Thalidomide.
Fostamatinib Fostamatinib The risk or severity of hypotension can be increased when Fostamatinib is combined with Thalidomide.
Avatrombopag Avatrombopag The metabolism of Thalidomide can be increased when combined with Avatrombopag.
Baricitinib Baricitinib The risk or severity of adverse effects can be increased when Thalidomide is combined with Baricitinib.
Lofexidine Lofexidine Lofexidine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Doravirine Doravirine The metabolism of Doravirine can be increased when combined with Thalidomide.
Cannabidiol Cannabidiol Cannabidiol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Dacomitinib Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Thalidomide.
Stiripentol Stiripentol Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be increased when combined with Thalidomide.
Methoxy Polyethylene Glycol-Epoetin Beta Injection Methoxy Polyethylene Glycol-Epoetin Beta Injection The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Thalidomide.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Paclitaxel.
Rifamycin Rifamycin The metabolism of Thalidomide can be decreased when combined with Rifamycin.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Ravulizumab.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Thalidomide can be increased when combined with Emapalumab.
Siponimod Siponimod The metabolism of Siponimod can be decreased when combined with Thalidomide.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Caplacizumab is combined with Thalidomide.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Thalidomide.
Esomeprazole Injection Esomeprazole Injection The metabolism of Esomeprazole can be decreased when combined with Thalidomide.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Risankizumab.
Alpelisib Alpelisib The serum concentration of Thalidomide can be decreased when it is combined with Alpelisib.
Brexanolone Injection Brexanolone Injection Brexanolone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Cladribine Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Thalidomide.
Solriamfetol Solriamfetol Solriamfetol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Triclabendazole Triclabendazole The metabolism of Thalidomide can be decreased when combined with Triclabendazole.
Istradefylline Istradefylline The metabolism of Istradefylline can be increased when combined with Thalidomide.
Fedratinib Fedratinib The metabolism of Fedratinib can be decreased when combined with Thalidomide.
Phenytoin Injection Phenytoin Injection Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Fosphenytoin Injection Fosphenytoin Injection Fosphenytoin may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Voxelotor Voxelotor The metabolism of Voxelotor can be decreased when combined with Thalidomide.
Avapritinib Avapritinib The metabolism of Avapritinib can be decreased when combined with Thalidomide.
Lumateperone Lumateperone Lumateperone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Lasmiditan Lasmiditan Lasmiditan may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Cenobamate Cenobamate The metabolism of Cenobamate can be increased when combined with Thalidomide.
Ozanimod Ozanimod The risk or severity of adverse effects can be increased when Thalidomide is combined with Ozanimod.
Selumetinib Selumetinib The metabolism of Selumetinib can be increased when combined with Thalidomide.
Rimegepant Rimegepant The metabolism of Rimegepant can be increased when combined with Thalidomide.
Selpercatinib Selpercatinib The serum concentration of Selpercatinib can be decreased when it is combined with Thalidomide.
Capmatinib Capmatinib The serum concentration of Capmatinib can be decreased when it is combined with Thalidomide.
Lemborexant Lemborexant Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Lemborexant.
Fenfluramine Fenfluramine Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Pralsetinib Pralsetinib The metabolism of Thalidomide can be decreased when combined with Pralsetinib.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Thalidomide can be decreased when it is combined with Satralizumab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the thrombogenic activities of Thalidomide.
Viloxazine Viloxazine Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Indomethacin Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Thalidomide.
Mefenamic Acid Mefenamic Acid The metabolism of Thalidomide can be decreased when combined with Mefenamic acid.
Naproxen Naproxen The metabolism of Thalidomide can be decreased when combined with Naproxen.
Trazodone Trazodone Trazodone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Hydroxyurea Hydroxyurea The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Thalidomide.
Floxuridine Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Thalidomide.
Phenobarbital Phenobarbital Phenobarbital may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Metaxalone Metaxalone Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Methotrexate Injection Methotrexate Injection The risk or severity of adverse effects can be increased when Methotrexate is combined with Thalidomide.
Levorphanol Levorphanol Levorphanol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Primidone Primidone Primidone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Methsuximide Methsuximide Methsuximide may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Diethylpropion Diethylpropion Diethylpropion may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Chlorpromazine Chlorpromazine Chlorpromazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Diazepam Diazepam Diazepam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Oxazepam Oxazepam Oxazepam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Flurazepam Flurazepam Flurazepam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Clorazepate Clorazepate Clorazepic acid may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Lorazepam Lorazepam Lorazepam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Phenoxybenzamine Phenoxybenzamine The risk or severity of adverse effects can be increased when Thalidomide is combined with Phenoxybenzamine.
Carmustine Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Thalidomide.
Codeine Codeine Codeine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Meprobamate Meprobamate Meprobamate may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Chlordiazepoxide Chlordiazepoxide Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Bromocriptine Bromocriptine Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Tranylcypromine Tranylcypromine Tranylcypromine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Phenelzine Phenelzine Phenelzine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Procarbazine Procarbazine Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Ergoloid Mesylates Ergoloid Mesylates Ergoloid mesylate may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Thalidomide.
Minocycline Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Prochlorperazine Prochlorperazine Prochlorperazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thioridazine Thioridazine Thioridazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Trifluoperazine Trifluoperazine Trifluoperazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Bleomycin Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Thalidomide.
Dapsone Dapsone The metabolism of Dapsone can be increased when combined with Thalidomide.
Sulfadiazine Sulfadiazine The metabolism of Thalidomide can be decreased when combined with Sulfadiazine.
Oxycodone Oxycodone Oxycodone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Methadone Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Thalidomide.
Oxybutynin Oxybutynin The metabolism of Oxybutynin can be increased when combined with Thalidomide.
Benztropine Benztropine Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
Maprotiline Maprotiline Maprotiline may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Ibuprofen Ibuprofen The metabolism of Ibuprofen can be decreased when combined with Thalidomide.
Trihexyphenidyl Trihexyphenidyl Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
Orphenadrine Orphenadrine Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Perphenazine Perphenazine Perphenazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Azathioprine Azathioprine The risk or severity of adverse effects can be increased when Azathioprine is combined with Thalidomide.
Fluphenazine Fluphenazine Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Amoxapine Amoxapine Amoxapine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Sulfasalazine Sulfasalazine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Thalidomide.
Hydrocortisone Hydrocortisone The metabolism of Hydrocortisone can be increased when combined with Thalidomide.
Lomustine Lomustine The risk or severity of adverse effects can be increased when Thalidomide is combined with Lomustine.
Doxorubicin Doxorubicin The risk or severity of adverse effects can be increased when Doxorubicin is combined with Thalidomide.
Cytarabine Cytarabine The risk or severity of adverse effects can be increased when Cytarabine is combined with Thalidomide.
Mechlorethamine Mechlorethamine The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Thalidomide.
Dactinomycin Dactinomycin The risk or severity of adverse effects can be increased when Dactinomycin is combined with Thalidomide.
Carbamazepine Carbamazepine Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Molindone Molindone Molindone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Methyldopa Methyldopa The risk or severity of adverse effects can be increased when Thalidomide is combined with Methyldopa.
Clonidine Clonidine Clonidine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Prazosin Prazosin The risk or severity of adverse effects can be increased when Thalidomide is combined with Prazosin.
Hydralazine Hydralazine The risk or severity of adverse effects can be increased when Thalidomide is combined with Hydralazine.
Cimetidine Cimetidine The metabolism of Thalidomide can be decreased when combined with Cimetidine.
Warfarin Warfarin The metabolism of Thalidomide can be decreased when combined with Warfarin.
Clonazepam Clonazepam Clonazepam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Promethazine Promethazine Promethazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Daunorubicin Daunorubicin The risk or severity of adverse effects can be increased when Daunorubicin is combined with Thalidomide.
Digoxin Digoxin Digoxin may decrease the cardiotoxic activities of Thalidomide.
Loxapine Loxapine Loxapine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Chloroquine Chloroquine The metabolism of Chloroquine can be increased when combined with Thalidomide.
Quinine Quinine Quinine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Ethosuximide Ethosuximide Ethosuximide may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Triamterene Triamterene The risk or severity of adverse effects can be increased when Triamterene is combined with Thalidomide.
Lactulose Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Thalidomide.
Sulfinpyrazone Sulfinpyrazone The metabolism of Thalidomide can be decreased when combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide The risk or severity of adverse effects can be increased when Thalidomide is combined with Chlorothiazide.
Chlorthalidone Chlorthalidone The risk or severity of adverse effects can be increased when Thalidomide is combined with Chlorthalidone.
Metolazone Metolazone The risk or severity of adverse effects can be increased when Thalidomide is combined with Metolazone.
Isosorbide Isosorbide Isosorbide may increase the thrombogenic activities of Thalidomide.
Clindamycin Injection Clindamycin Injection The metabolism of Clindamycin can be increased when combined with Thalidomide.
Secobarbital Secobarbital Secobarbital may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Desipramine Desipramine Desipramine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Amitriptyline Amitriptyline Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Imipramine Imipramine Imipramine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Probenecid Probenecid The metabolism of Thalidomide can be decreased when combined with Probenecid.
Quinidine Quinidine Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Quinidine.
Isoniazid Isoniazid The metabolism of Thalidomide can be decreased when combined with Isoniazid.
Disopyramide Disopyramide Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Disopyramide.
Valproic Acid Valproic Acid Valproic acid may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Tamoxifen Tamoxifen The metabolism of Thalidomide can be decreased when combined with Tamoxifen.
Mitomycin Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Thalidomide.
Butabarbital Butabarbital Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Methimazole Methimazole The risk or severity of adverse effects can be increased when Methimazole is combined with Thalidomide.
Propylthiouracil Propylthiouracil The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Thalidomide.
Chlorpropamide Chlorpropamide The metabolism of Thalidomide can be decreased when combined with Chlorpropamide.
Tolbutamide Tolbutamide The metabolism of Tolbutamide can be decreased when combined with Thalidomide.
Tolazamide Tolazamide The metabolism of Thalidomide can be decreased when combined with Tolazamide.
Dextromethorphan Dextromethorphan Dextromethorphan may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Cyclobenzaprine Cyclobenzaprine Cyclobenzaprine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Baclofen Baclofen Baclofen may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Doxylamine Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Cyproheptadine Cyproheptadine Cyproheptadine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Clemastine Clemastine Clemastine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Chlorpheniramine Chlorpheniramine Chlorpheniramine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Brompheniramine Brompheniramine Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Meclizine Meclizine Meclizine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Methyclothiazide Methyclothiazide The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Thalidomide.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of adverse effects can be increased when Thalidomide is combined with Hydrochlorothiazide.
Dantrolene Dantrolene Dantrolene may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Chlorzoxazone Chlorzoxazone Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Carisoprodol Carisoprodol Carisoprodol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Methocarbamol Methocarbamol Methocarbamol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Disulfiram Disulfiram The metabolism of Disulfiram can be increased when combined with Thalidomide.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The serum concentration of Propranolol can be increased when it is combined with Thalidomide.
Minoxidil Minoxidil The risk or severity of adverse effects can be increased when Thalidomide is combined with Minoxidil.
Nortriptyline Nortriptyline Nortriptyline may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Spironolactone Spironolactone The risk or severity of adverse effects can be increased when Spironolactone is combined with Thalidomide.
Amphotericin B Injection Amphotericin B Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Thalidomide.
Mercaptopurine Mercaptopurine The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Thalidomide.
Nadolol Nadolol The risk or severity of adverse effects can be increased when Thalidomide is combined with Nadolol.
Butorphanol Injection Butorphanol Injection Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Nalbuphine Injection Nalbuphine Injection Nalbuphine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Allopurinol Allopurinol The risk or severity of adverse effects can be increased when Allopurinol is combined with Thalidomide.
Trimethobenzamide Trimethobenzamide Trimethobenzamide may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Flavoxate Flavoxate Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Papaverine Papaverine The risk or severity of adverse effects can be increased when Thalidomide is combined with Papaverine.
Fluorouracil Injection Fluorouracil Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Thalidomide.
Colchicine Colchicine The risk or severity of adverse effects can be increased when Thalidomide is combined with Colchicine.
Dacarbazine Dacarbazine The risk or severity of adverse effects can be increased when Dacarbazine is combined with Thalidomide.
Acetazolamide Acetazolamide Acetazolamide may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Thalidomide.
Pyrantel Pyrantel Pyrantel may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thiotepa Injection Thiotepa Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Thiotepa.
Vincristine Injection Vincristine Injection The risk or severity of adverse effects can be increased when Vincristine is combined with Thalidomide.
Captopril Captopril The risk or severity of adverse effects can be increased when Thalidomide is combined with Captopril.
Dipyridamole Dipyridamole The risk or severity of bleeding can be increased when Dipyridamole is combined with Thalidomide.
Isoxsuprine Isoxsuprine The risk or severity of adverse effects can be increased when Thalidomide is combined with Isoxsuprine.
Vinblastine Vinblastine The risk or severity of adverse effects can be increased when Vinblastine is combined with Thalidomide.
Ethacrynic Acid Ethacrynic Acid The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Thalidomide.
Metoprolol Metoprolol The risk or severity of adverse effects can be increased when Thalidomide is combined with Metoprolol.
Hydroxyzine Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thiothixene Thiothixene Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Aspirin Aspirin The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Thalidomide.
Chlorambucil Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Thalidomide.
Alprazolam Alprazolam Alprazolam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Temazepam Temazepam Temazepam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Triazolam Triazolam Triazolam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Dicyclomine Dicyclomine Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hyoscyamine Hyoscyamine Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
Propantheline Propantheline Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
Trimethoprim Trimethoprim The metabolism of Thalidomide can be decreased when combined with Trimethoprim.
Diltiazem Diltiazem The metabolism of Diltiazem can be increased when combined with Thalidomide.
Nifedipine Nifedipine The metabolism of Nifedipine can be increased when combined with Thalidomide.
Timolol Timolol The metabolism of Timolol can be decreased when combined with Thalidomide.
Verapamil Verapamil The metabolism of Verapamil can be increased when combined with Thalidomide.
Atenolol Atenolol The risk or severity of adverse effects can be increased when Thalidomide is combined with Atenolol.
Pindolol Pindolol Pindolol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Cisplatin Injection Cisplatin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Thalidomide.
Piroxicam Piroxicam The metabolism of Thalidomide can be decreased when combined with Piroxicam.
Bumetanide Bumetanide The risk or severity of adverse effects can be increased when Bumetanide is combined with Thalidomide.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Streptozocin is combined with Thalidomide.
Etoposide Etoposide The risk or severity of adverse effects can be increased when Etoposide is combined with Thalidomide.
Glyburide Glyburide The metabolism of Thalidomide can be decreased when combined with Glyburide.
Glipizide Glipizide The metabolism of Glipizide can be decreased when combined with Thalidomide.
Indapamide Indapamide The risk or severity of adverse effects can be increased when Thalidomide is combined with Indapamide.
Pentoxifylline Pentoxifylline The risk or severity of bleeding can be increased when Pentoxifylline is combined with Thalidomide.
Pentamidine Injection Pentamidine Injection The metabolism of Pentamidine can be increased when combined with Thalidomide.
Labetalol Labetalol The metabolism of Labetalol can be decreased when combined with Thalidomide.
Gemfibrozil Gemfibrozil The metabolism of Thalidomide can be decreased when combined with Gemfibrozil.
Guanabenz Guanabenz Thalidomide may increase the hypotensive activities of Guanabenz.
Pimozide Pimozide Pimozide may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Enalapril Enalapril The risk or severity of adverse effects can be increased when Thalidomide is combined with Enalapril.
Flurbiprofen Flurbiprofen The metabolism of Thalidomide can be decreased when combined with Flurbiprofen.
Amiodarone Amiodarone The metabolism of Amiodarone can be decreased when combined with Thalidomide.
Buspirone Buspirone The metabolism of Buspirone can be increased when combined with Thalidomide.
Lovastatin Lovastatin The metabolism of Lovastatin can be increased when combined with Thalidomide.
Diclofenac Diclofenac The metabolism of Thalidomide can be decreased when combined with Diclofenac.
Fluoxetine Fluoxetine Fluoxetine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Nimodipine Nimodipine The risk or severity of adverse effects can be increased when Thalidomide is combined with Nimodipine.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Thalidomide.
Clozapine Clozapine Clozapine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Estazolam Estazolam Estazolam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Idarubicin Idarubicin The risk or severity of adverse effects can be increased when Thalidomide is combined with Idarubicin.
Fludarabine Injection Fludarabine Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Fludarabine.
Pentostatin Injection Pentostatin Injection The risk or severity of adverse effects can be increased when Pentostatin is combined with Thalidomide.
Clarithromycin Clarithromycin The metabolism of Clarithromycin can be increased when combined with Thalidomide.
Benazepril Benazepril The risk or severity of adverse effects can be increased when Thalidomide is combined with Benazepril.
Etodolac Etodolac The metabolism of Thalidomide can be decreased when combined with Etodolac.
Felodipine Felodipine The metabolism of Felodipine can be increased when combined with Thalidomide.
Fosinopril Fosinopril The risk or severity of adverse effects can be increased when Thalidomide is combined with Fosinopril.
Nabumetone Nabumetone The metabolism of Thalidomide can be decreased when combined with Nabumetone.
Quinapril Quinapril The risk or severity of adverse effects can be increased when Thalidomide is combined with Quinapril.
Ramipril Ramipril The risk or severity of adverse effects can be increased when Thalidomide is combined with Ramipril.
Simvastatin Simvastatin The metabolism of Simvastatin can be increased when combined with Thalidomide.
Epoetin Alfa, Injection Epoetin Alfa, Injection The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Thalidomide.
Amlodipine Amlodipine The risk or severity of adverse effects can be increased when Thalidomide is combined with Amlodipine.
Teniposide Injection Teniposide Injection The risk or severity of adverse effects can be increased when Teniposide is combined with Thalidomide.
Lisinopril Lisinopril The risk or severity of adverse effects can be increased when Thalidomide is combined with Lisinopril.
Atovaquone Atovaquone The metabolism of Thalidomide can be decreased when combined with Atovaquone.
Sotalol Sotalol The risk or severity of adverse effects can be increased when Sotalol is combined with Thalidomide.
Bisoprolol Bisoprolol The risk or severity of adverse effects can be increased when Thalidomide is combined with Bisoprolol.
Zolpidem Zolpidem Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Thalidomide.
Terazosin Terazosin The risk or severity of adverse effects can be increased when Thalidomide is combined with Terazosin.
Isradipine Isradipine The risk or severity of adverse effects can be increased when Thalidomide is combined with Isradipine.
Omeprazole Omeprazole The metabolism of Omeprazole can be decreased when combined with Thalidomide.
Cisapride Cisapride Cisapride may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Gabapentin Gabapentin Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be increased when combined with Thalidomide.
Venlafaxine Venlafaxine Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Fluvoxamine Fluvoxamine Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Nefazodone Nefazodone Nefazodone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Lamotrigine Lamotrigine Lamotrigine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Losartan Losartan The risk or severity of adverse effects can be increased when Thalidomide is combined with Losartan.
Tramadol Tramadol Tramadol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Vinorelbine Injection Vinorelbine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Thalidomide.
Carboplatin Injection Carboplatin Injection The risk or severity of adverse effects can be increased when Carboplatin is combined with Thalidomide.
Moexipril Moexipril The risk or severity of adverse effects can be increased when Thalidomide is combined with Moexipril.
Lansoprazole Lansoprazole The metabolism of Lansoprazole can be decreased when combined with Thalidomide.
Ifosfamide Injection Ifosfamide Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Ifosfamide.
Pegaspargase Injection Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Thalidomide.
Nicardipine Nicardipine The metabolism of Thalidomide can be decreased when combined with Nicardipine.
Bupropion Bupropion Bupropion may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Ticlopidine Ticlopidine The risk or severity of bleeding can be increased when Ticlopidine is combined with Thalidomide.
Saquinavir Saquinavir The metabolism of Saquinavir can be increased when combined with Thalidomide.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding can be increased when Dalteparin is combined with Thalidomide.
Nisoldipine Nisoldipine The metabolism of Nisoldipine can be increased when combined with Thalidomide.
Riluzole Riluzole Riluzole may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Amifostine Injection Amifostine Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Amifostine.
Glimepiride Glimepiride The metabolism of Thalidomide can be decreased when combined with Glimepiride.
Anastrozole Anastrozole The risk or severity of cardiotoxicity can be increased when Thalidomide is combined with Anastrozole.
Gemcitabine Injection Gemcitabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Thalidomide.
Indinavir Indinavir The metabolism of Indinavir can be increased when combined with Thalidomide.
Ritonavir Ritonavir The metabolism of Ritonavir can be increased when combined with Thalidomide.
Docetaxel Injection Docetaxel Injection The risk or severity of adverse effects can be increased when Thalidomide is combined with Docetaxel.
Clomipramine Clomipramine Clomipramine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Zafirlukast Zafirlukast The metabolism of Thalidomide can be decreased when combined with Zafirlukast.
Mirtazapine Mirtazapine Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Trandolapril Trandolapril The risk or severity of adverse effects can be increased when Thalidomide is combined with Trandolapril.
Topiramate Topiramate Topiramate may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Zileuton Zileuton The metabolism of Thalidomide can be decreased when combined with Zileuton.
Valsartan Valsartan The metabolism of Thalidomide can be decreased when combined with Valsartan.
Pramipexole Pramipexole Thalidomide may increase the sedative activities of Pramipexole.
Donepezil Donepezil Donepezil may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Nelfinavir Nelfinavir The metabolism of Thalidomide can be decreased when combined with Nelfinavir.
Carvedilol Carvedilol The risk or severity of adverse effects can be increased when Thalidomide is combined with Carvedilol.
Nilutamide Nilutamide The metabolism of Thalidomide can be decreased when combined with Nilutamide.
Flutamide Flutamide The metabolism of Flutamide can be increased when combined with Thalidomide.
Selegiline Selegiline Selegiline may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Bicalutamide Bicalutamide The metabolism of Thalidomide can be decreased when combined with Bicalutamide.
Sertraline Sertraline Sertraline may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Irbesartan Irbesartan The risk or severity of adverse effects can be increased when Thalidomide is combined with Irbesartan.
Tamsulosin Tamsulosin The risk or severity of adverse effects can be increased when Tamsulosin is combined with Thalidomide.
Ropinirole Ropinirole Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Finasteride Finasteride The metabolism of Finasteride can be increased when combined with Thalidomide.
Quetiapine Quetiapine Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Cetirizine Cetirizine Cetirizine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Paroxetine Paroxetine Paroxetine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Tolcapone Tolcapone Tolcapone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Citalopram Citalopram Citalopram may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Capecitabine Capecitabine The metabolism of Capecitabine can be decreased when combined with Thalidomide.
Efavirenz Efavirenz Efavirenz may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Sildenafil Sildenafil The metabolism of Sildenafil can be increased when combined with Thalidomide.
Trastuzumab Injection Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Thalidomide.
Celecoxib Celecoxib The metabolism of Thalidomide can be decreased when combined with Celecoxib.
Rosiglitazone Rosiglitazone The metabolism of Thalidomide can be decreased when combined with Rosiglitazone.
Tolterodine Tolterodine Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.
Nateglinide Nateglinide The metabolism of Nateglinide can be increased when combined with Thalidomide.
Levetiracetam Levetiracetam Levetiracetam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Rabeprazole Rabeprazole The metabolism of Rabeprazole can be decreased when combined with Thalidomide.
Terbinafine Terbinafine The metabolism of Thalidomide can be decreased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists